Asston Pharmaceuticals Limited share price
BSE: APL
Key numbers
- Market cap
- ₹ 109 Cr
- Current price
- ₹ 99.75
- 52-week high / low
- ₹ 126 / 60
- Stock P/E
- 20.3
- Book value
- ₹ 45.7
- Dividend yield
- 0.00%
- ROCE
- 16.7%
- ROE
- 15.5%
- Debt to equity
- 0.13
- Sales growth (3 yrs)
- 57.3%
- Profit growth (3 yrs)
- 54.0%
- 1-year return
- -0.7%
About Asston Pharmaceuticals Limited
Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hydrochloride sustained release, metformin hydrochloride, metronidazole, multivitamin, nitrofurantoin, ofloxacin and ornidazole, pantoprazole, paracetamol, paracetamol, phenylephrine HCL, chlorpheniramine maleate and caffeine, prednisolone, pregabalin SR and methylcobalamin, pyridoxine HCL, rifampicin and isoniazid, rifampicin, isoniazid, pyrazinamide and ethambutol HCL, sildenafil, tadalafil, telmisartan, and zinc sulphate. It also offers capsules, including amoxicillin, ampicillin and cloxacillin, ampicillin, b-complex, cloxacillin, danazol, diclofenac, ibuprofen, paracetamol, caffeine, indomethacin, itraconazole, mecobalamin, alpha lipoic…
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 9 | 10 |
| Operating profit | 3 | -3 |
| Net profit | 2 | 0 |
| EPS (₹) | 2.29 | 1.14 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.